$OSIP Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in OSI PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in OSI PHARMACEUTICALS INC. Get notifications about new insider transactions in OSI PHARMACEUTICALS INC for free.
Page: < prev 1 ... 9 10 11 12 13 14 15 16 17 ... 19 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Option Exercise | M | 9.25 | 4,167 | 38,545 | 7,499 | |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Sell | S | 64.83 | 321 | 20,810 | 19,890 | 20.2 K to 19.9 K (-1.59 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Sell | S | 64.60 | 339 | 21,899 | 20,211 | 20.6 K to 20.2 K (-1.65 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Sell | S | 64.54 | 36 | 2,323 | 20,550 | 20.6 K to 20.6 K (-0.17 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Sell | S | 64.53 | 36 | 2,323 | 20,586 | 20.6 K to 20.6 K (-0.17 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Sell | S | 64.52 | 143 | 9,226 | 20,622 | 20.8 K to 20.6 K (-0.69 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Sell | S | 64.49 | 89 | 5,740 | 20,765 | 20.9 K to 20.8 K (-0.43 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Sell | S | 64.40 | 70 | 4,508 | 20,854 | 20.9 K to 20.9 K (-0.33 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Sell | S | 64.32 | 55 | 3,538 | 20,924 | 21 K to 20.9 K (-0.26 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Sell | S | 64.31 | 36 | 2,315 | 20,979 | 21 K to 21 K (-0.17 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Sell | S | 64.30 | 1,357 | 87,255 | 21,015 | 22.4 K to 21 K (-6.07 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Sell | S | 64.25 | 2,239 | 143,856 | 22,372 | 24.6 K to 22.4 K (-9.10 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Sell | S | 64.21 | 89 | 5,715 | 24,611 | 24.7 K to 24.6 K (-0.36 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Sell | S | 64.20 | 357 | 22,919 | 24,700 | 25.1 K to 24.7 K (-1.42 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Buy | M | 9.25 | 4,167 | 38,545 | 25,057 | 20.9 K to 25.1 K (+19.95 %) |
Oct 20 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Option Exercise | M | 45.01 | 3,400 | 153,034 | 126,600 | |
Oct 20 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 65.00 | 3,400 | 221,000 | 4,255 | 7.7 K to 4.3 K (-44.42 %) |
Oct 20 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Buy | M | 45.01 | 3,400 | 153,034 | 7,655 | 4.3 K to 7.7 K (+79.91 %) |
Oct 18 2004 | OSIP | OSI PHARMACEUTICAL ... | SIMON ROBERT L | VP, Global Reg. Aff ... | Option Exercise | M | 21.55 | 3,500 | 75,425 | 17,300 | |
Oct 18 2004 | OSIP | OSI PHARMACEUTICAL ... | SIMON ROBERT L | VP, Global Reg. Aff ... | Sell | S | 63.64 | 1,322 | 84,132 | 2,599 | 3.9 K to 2.6 K (-33.72 %) |
Oct 18 2004 | OSIP | OSI PHARMACEUTICAL ... | SIMON ROBERT L | VP, Global Reg. Aff ... | Sell | S | 63.62 | 704 | 44,788 | 3,921 | 4.6 K to 3.9 K (-15.22 %) |
Oct 18 2004 | OSIP | OSI PHARMACEUTICAL ... | SIMON ROBERT L | VP, Global Reg. Aff ... | Sell | S | 63.60 | 1,474 | 93,746 | 4,625 | 6.1 K to 4.6 K (-24.17 %) |
Oct 18 2004 | OSIP | OSI PHARMACEUTICAL ... | SIMON ROBERT L | VP, Global Reg. Aff ... | Buy | M | 21.55 | 3,500 | 75,425 | 6,099 | 2.6 K to 6.1 K (+134.67 %) |
Oct 18 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Option Exercise | M | 6.50 | 2,917 | 18,961 | 32,083 | |
Oct 18 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 63.64 | 1,101 | 70,068 | 5,577 | 6.7 K to 5.6 K (-16.49 %) |
Oct 18 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 63.62 | 588 | 37,409 | 6,678 | 7.3 K to 6.7 K (-8.09 %) |
Oct 18 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 63.60 | 1,228 | 78,101 | 7,266 | 8.5 K to 7.3 K (-14.46 %) |
Oct 18 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Buy | M | 6.50 | 2,917 | 18,961 | 8,494 | 5.6 K to 8.5 K (+52.30 %) |
Oct 18 2004 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Sell | S | 63.64 | 378 | 24,056 | 10,970 | 11.3 K to 11 K (-3.33 %) |
Oct 18 2004 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Sell | S | 63.62 | 201 | 12,788 | 11,348 | 11.5 K to 11.3 K (-1.74 %) |
Oct 18 2004 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Sell | S | 63.60 | 421 | 26,776 | 11,549 | 12 K to 11.5 K (-3.52 %) |
Oct 18 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Option Exercise | M | 30.74 | 528 | 16,231 | 13,972 | |
Oct 18 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 63.64 | 199 | 12,664 | 0 | 199 to 0 (-100.00 %) |
Oct 18 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 63.62 | 107 | 6,807 | 199 | 306 to 199 (-34.97 %) |
Oct 18 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 63.60 | 222 | 14,119 | 306 | 528 to 306 (-42.05 %) |
Oct 18 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Buy | M | 30.74 | 528 | 16,231 | 528 | 0 to 528 |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Option Exercise | M | 30.74 | 1,423 | 43,743 | 17,652 | |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Option Exercise | M | 21.55 | 577 | 12,434 | 4,608 | |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 61.83 | 81 | 5,008 | 0 | 81 to 0 (-100.00 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 61.75 | 18 | 1,112 | 81 | 99 to 81 (-18.18 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 61.60 | 143 | 8,809 | 99 | 242 to 99 (-59.09 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 61.55 | 71 | 4,370 | 242 | 313 to 242 (-22.68 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 61.30 | 36 | 2,207 | 313 | 349 to 313 (-10.32 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 61.25 | 9 | 551 | 349 | 358 to 349 (-2.51 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 61.19 | 10 | 612 | 358 | 368 to 358 (-2.72 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 61.18 | 36 | 2,202 | 368 | 404 to 368 (-8.91 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 61.11 | 9 | 550 | 404 | 413 to 404 (-2.18 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 61.10 | 233 | 14,236 | 413 | 646 to 413 (-36.07 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 61.09 | 25 | 1,527 | 646 | 671 to 646 (-3.73 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 61.07 | 36 | 2,199 | 671 | 707 to 671 (-5.09 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 61.05 | 27 | 1,648 | 707 | 734 to 707 (-3.68 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 61.00 | 209 | 12,749 | 734 | 943 to 734 (-22.16 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 60.96 | 896 | 54,620 | 943 | 1.8 K to 943 (-48.72 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 60.83 | 8 | 487 | 1,839 | 1.8 K to 1.8 K (-0.43 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 60.81 | 18 | 1,095 | 1,847 | 1.9 K to 1.8 K (-0.97 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 60.80 | 45 | 2,736 | 1,865 | 1.9 K to 1.9 K (-2.36 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 60.78 | 9 | 547 | 1,910 | 1.9 K to 1.9 K (-0.47 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 60.77 | 18 | 1,094 | 1,919 | 1.9 K to 1.9 K (-0.93 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 60.76 | 26 | 1,580 | 1,937 | 2 K to 1.9 K (-1.32 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 60.75 | 37 | 2,248 | 1,963 | 2 K to 2 K (-1.85 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Buy | M | 30.74 | 1,423 | 43,743 | 2,000 | 577 to 2 K (+246.62 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Buy | M | 21.55 | 577 | 12,434 | 577 | 0 to 577 |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Option Exercise | M | 9.25 | 4,167 | 38,545 | 11,666 | |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Sell | S | 61.83 | 208 | 12,861 | 20,890 | 21.1 K to 20.9 K (-0.99 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Sell | S | 61.75 | 46 | 2,841 | 21,098 | 21.1 K to 21.1 K (-0.22 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Sell | S | 61.60 | 370 | 22,792 | 21,144 | 21.5 K to 21.1 K (-1.72 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Sell | S | 61.55 | 185 | 11,387 | 21,514 | 21.7 K to 21.5 K (-0.85 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Sell | S | 61.30 | 93 | 5,701 | 21,699 | 21.8 K to 21.7 K (-0.43 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Sell | S | 61.25 | 23 | 1,409 | 21,792 | 21.8 K to 21.8 K (-0.11 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Sell | S | 61.19 | 23 | 1,407 | 21,815 | 21.8 K to 21.8 K (-0.11 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Sell | S | 61.18 | 93 | 5,690 | 21,838 | 21.9 K to 21.8 K (-0.42 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Sell | S | 61.11 | 23 | 1,406 | 21,931 | 22 K to 21.9 K (-0.10 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Sell | S | 61.10 | 603 | 36,843 | 21,954 | 22.6 K to 22 K (-2.67 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Sell | S | 61.09 | 69 | 4,215 | 22,557 | 22.6 K to 22.6 K (-0.30 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Sell | S | 61.07 | 93 | 5,680 | 22,626 | 22.7 K to 22.6 K (-0.41 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Sell | S | 61.05 | 69 | 4,212 | 22,719 | 22.8 K to 22.7 K (-0.30 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Sell | S | 61.00 | 540 | 32,940 | 22,788 | 23.3 K to 22.8 K (-2.31 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Sell | S | 60.96 | 2,314 | 141,061 | 23,328 | 25.6 K to 23.3 K (-9.02 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Sell | S | 60.83 | 22 | 1,338 | 25,642 | 25.7 K to 25.6 K (-0.09 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Sell | S | 60.81 | 46 | 2,797 | 25,664 | 25.7 K to 25.7 K (-0.18 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Sell | S | 60.80 | 116 | 7,053 | 25,710 | 25.8 K to 25.7 K (-0.45 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Sell | S | 60.78 | 23 | 1,398 | 25,826 | 25.8 K to 25.8 K (-0.09 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Sell | S | 60.77 | 46 | 2,795 | 25,849 | 25.9 K to 25.8 K (-0.18 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Sell | S | 60.76 | 69 | 4,192 | 25,895 | 26 K to 25.9 K (-0.27 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Sell | S | 60.75 | 93 | 5,650 | 25,964 | 26.1 K to 26 K (-0.36 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Buy | M | 9.25 | 4,167 | 38,545 | 26,057 | 21.9 K to 26.1 K (+19.04 %) |
Oct 12 2004 | OSIP | OSI PHARMACEUTICAL ... | LOVENBERG WALTER M PHD | Director | Option Exercise | M | 9.25 | 1,667 | 15,420 | 18,333 | |
Oct 12 2004 | OSIP | OSI PHARMACEUTICAL ... | LOVENBERG WALTER M PHD | Director | Sell | S | 61.90 | 1,667 | 103,187 | 8,052 | 9.7 K to 8.1 K (-17.15 %) |
Oct 12 2004 | OSIP | OSI PHARMACEUTICAL ... | LOVENBERG WALTER M PHD | Director | Buy | M | 9.25 | 1,667 | 15,420 | 9,719 | 8.1 K to 9.7 K (+20.70 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Option Exercise | M | 7.09 | 2,750 | 19,509 | 11,155 | |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 61.83 | 111 | 6,863 | 4,766 | 4.9 K to 4.8 K (-2.28 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 61.75 | 25 | 1,544 | 4,877 | 4.9 K to 4.9 K (-0.51 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 61.60 | 197 | 12,135 | 4,902 | 5.1 K to 4.9 K (-3.86 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 61.55 | 99 | 6,093 | 5,099 | 5.2 K to 5.1 K (-1.90 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 61.30 | 49 | 3,004 | 5,198 | 5.2 K to 5.2 K (-0.93 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 61.25 | 12 | 735 | 5,247 | 5.3 K to 5.2 K (-0.23 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 61.19 | 12 | 734 | 5,259 | 5.3 K to 5.3 K (-0.23 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 61.18 | 49 | 2,998 | 5,271 | 5.3 K to 5.3 K (-0.92 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 61.11 | 12 | 733 | 5,320 | 5.3 K to 5.3 K (-0.23 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 61.10 | 320 | 19,552 | 5,332 | 5.7 K to 5.3 K (-5.66 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 61.09 | 37 | 2,260 | 5,652 | 5.7 K to 5.7 K (-0.65 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 61.07 | 49 | 2,992 | 5,698 | 5.7 K to 5.7 K (-0.85 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 61.05 | 37 | 2,259 | 5,738 | 5.8 K to 5.7 K (-0.64 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 61.00 | 287 | 17,507 | 5,775 | 6.1 K to 5.8 K (-4.73 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 60.96 | 1,231 | 75,042 | 6,062 | 7.3 K to 6.1 K (-16.88 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 60.83 | 12 | 730 | 7,293 | 7.3 K to 7.3 K (-0.16 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 60.81 | 25 | 1,520 | 7,305 | 7.3 K to 7.3 K (-0.34 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 60.80 | 62 | 3,770 | 7,330 | 7.4 K to 7.3 K (-0.84 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 60.78 | 12 | 729 | 7,392 | 7.4 K to 7.4 K (-0.16 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 60.77 | 25 | 1,519 | 7,404 | 7.4 K to 7.4 K (-0.34 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 60.76 | 38 | 2,309 | 7,429 | 7.5 K to 7.4 K (-0.51 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 60.75 | 49 | 2,977 | 7,467 | 7.5 K to 7.5 K (-0.65 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Buy | M | 7.09 | 2,750 | 19,509 | 7,516 | 4.8 K to 7.5 K (+57.70 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Option Exercise | M | 16.81 | 500 | 8,407 | 35,000 | |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 61.83 | 19 | 1,175 | 2,890 | 2.9 K to 2.9 K (-0.65 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 61.75 | 4 | 247 | 2,909 | 2.9 K to 2.9 K (-0.14 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 61.60 | 37 | 2,279 | 2,913 | 3 K to 2.9 K (-1.25 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 61.55 | 18 | 1,108 | 2,950 | 3 K to 3 K (-0.61 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 61.30 | 9 | 552 | 2,968 | 3 K to 3 K (-0.30 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 61.25 | 4 | 245 | 2,977 | 3 K to 3 K (-0.13 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 61.19 | 2 | 122 | 2,981 | 3 K to 3 K (-0.07 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 61.18 | 9 | 551 | 2,983 | 3 K to 3 K (-0.30 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 61.11 | 3 | 183 | 2,992 | 3 K to 3 K (-0.10 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 61.10 | 57 | 3,483 | 2,995 | 3.1 K to 3 K (-1.87 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 61.09 | 7 | 428 | 3,052 | 3.1 K to 3.1 K (-0.23 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 61.07 | 9 | 550 | 3,059 | 3.1 K to 3.1 K (-0.29 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 61.05 | 7 | 427 | 3,068 | 3.1 K to 3.1 K (-0.23 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 61.00 | 52 | 3,172 | 3,075 | 3.1 K to 3.1 K (-1.66 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 60.96 | 223 | 13,594 | 3,127 | 3.4 K to 3.1 K (-6.66 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 60.83 | 3 | 182 | 3,350 | 3.4 K to 3.4 K (-0.09 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 60.81 | 4 | 243 | 3,353 | 3.4 K to 3.4 K (-0.12 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 60.80 | 11 | 669 | 3,357 | 3.4 K to 3.4 K (-0.33 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 60.78 | 2 | 122 | 3,368 | 3.4 K to 3.4 K (-0.06 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 60.77 | 5 | 304 | 3,370 | 3.4 K to 3.4 K (-0.15 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 60.76 | 7 | 425 | 3,375 | 3.4 K to 3.4 K (-0.21 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 60.75 | 8 | 486 | 3,382 | 3.4 K to 3.4 K (-0.24 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Buy | M | 16.81 | 500 | 8,407 | 3,390 | 2.9 K to 3.4 K (+17.30 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Option Exercise | M | 30.74 | 2,300 | 70,702 | 46,000 | |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Option Exercise | M | 21.55 | 798 | 17,197 | 6,372 | |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 61.83 | 125 | 7,729 | 4,255 | 4.4 K to 4.3 K (-2.85 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 61.75 | 28 | 1,729 | 4,380 | 4.4 K to 4.4 K (-0.64 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 61.60 | 222 | 13,675 | 4,408 | 4.6 K to 4.4 K (-4.79 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 61.55 | 111 | 6,832 | 4,630 | 4.7 K to 4.6 K (-2.34 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 61.30 | 55 | 3,372 | 4,741 | 4.8 K to 4.7 K (-1.15 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 61.25 | 14 | 858 | 4,796 | 4.8 K to 4.8 K (-0.29 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 61.19 | 14 | 857 | 4,810 | 4.8 K to 4.8 K (-0.29 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 61.18 | 55 | 3,365 | 4,824 | 4.9 K to 4.8 K (-1.13 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 61.11 | 14 | 856 | 4,879 | 4.9 K to 4.9 K (-0.29 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 61.10 | 362 | 22,118 | 4,893 | 5.3 K to 4.9 K (-6.89 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 61.09 | 40 | 2,444 | 5,255 | 5.3 K to 5.3 K (-0.76 %) |